在儿科期刊中对亚托皮肤炎出版物的代表性不足:图书统计分析
Barak Zlakishvili1, Sarah Weissmann2,3, Amir Horev2,4
1Hebrew University School of Medicine, Jerusalem.
Dermatology reports
|December 13, 2024
概括
这份图书统计分析显示,在儿科文献中,有关亚托皮性皮肤炎 (AD) 研究的代表性不足. 这可能会影响AD患者的临床护理和社会成本.
科学领域:
- 图书统计学 图书统计学
- 皮肤病学 皮肤病学
- 儿科 儿科 儿科
背景情况:
- 亚托皮炎 (AD) 是一种常见的儿科皮肤疾病.
- 对阿尔茨海默病有广泛的研究,但儿科代表性尚不清楚.
研究的目的:
- 评估在最常引用的亚托皮性皮肤炎文献中的儿科代表性.
- 确定对临床护理和社会成本的潜在影响.
主要方法:
- 对标题中含有"atopic"和"dermatitis"或"eczema"的出版物的图书统计分析.
- 数据来源于科学网络引用索引数据库的数据.
- 文章按年度引用 (AC) 和影响因子排名.
主要成果:
- 获取的出版物数量为 28,360 份.
- 皮肤病学文献显示,与一般医学和儿科相比,引用和使用指标显著更高.
- 在儿科文献中发现了AD出版物的显著不足.
结论:
- 这项研究强调了儿童医学文献中对亚托皮性皮肤炎研究的代表性不足.
- 这种差异可能会对儿科阿尔茨海默症患者的临床护理产生负面影响.
- 代表人数不足也可能影响与亚托皮炎相关的年度社会支出.
相关概念视频
Allergic Reactions
26.7K
Overview
26.7K
Skin Diseases and Disorders
5.4K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
982
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
982
Pharmacokinetics in Pediatric Patients: Drug Distribution
562
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562
Pharmacokinetics in Pediatric Patients: Drug Metabolism
417
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
417
Pharmacokinetics in Pediatric Patients: Drug Excretion
414
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
414


